Streetbeat News

Stock Prices

HTOO

Fusion Fuel Green's stock is trading higher following the announcement that the European Commission has approved the IPCEI for its 630 MW HEVO-Portugal Project. This approval is a significant milestone for the company, indicating strong support from the European Union for its green hydrogen project.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 7:00 pm

MATICUSD

Polygon (CRYPTO: MATIC) has seen a 3.58% increase in price over the last 24 hours, reaching $0.93. This is part of a larger trend, with a 10% gain over the past week from $0.85. The coin's all-time high is $2.92. Trading volume has risen by 65% in the past week, while the circulating supply decreased by 0.61% to 9.28 billion, approximately 92.83% of its max supply. MATIC's market cap ranks it #15 at $8.63 billion.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 7:00 pm

BHVN

CERE

KRTX

XENE

RBC Capital Markets has initiated coverage on Biohaven Ltd (NYSE:BHVN) with an Outperform, Speculative Risk rating, and a price target of $62, citing its promising approach in the neuro-psych space. The analyst is optimistic about Biohaven's Kv7 modulators for epilepsy and mood disorders, highlighting its potential $3.2 billion market and fast follower strategy leveraging competitor data, notably from Xenon Pharmaceuticals Inc (NASDAQ:XENE). Despite potential risks, the unique safety profile and upcoming Phase 3 trial results for BHV-7000 are seen as positive indicators. The success of similar drugs by Karuna Therapeutics Inc (NASDAQ:KRTX) and Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) in the schizophrenia market supports the potential for increased adoption in the epilepsy and mood disorder market.

Portfolio Pulse from Vandana Singh

February 16, 2024 | 6:58 pm

BIO

Bio-Rad Laboratories' stock is trading higher after the company reported its fourth-quarter earnings.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:58 pm

AMAT

Applied Materials Inc (NASDAQ:AMAT) shares surged after reporting Q1 FY24 earnings and sales above analyst estimates. The company also provided optimistic Q2 guidance. Several analysts raised their price targets, citing the company's leverage in AI silicon technology, product portfolio, and market position as key drivers. Analysts expect continued industry recovery and earnings growth for Applied Materials.

Portfolio Pulse from Lekha Gupta

February 16, 2024 | 6:56 pm

GXAI

Gaxos.Ai's stock price increased following the announcement of its gaming division launching an AI solution for game developers and studios. This move is expected to enhance the company's offerings in the gaming industry and potentially increase its market share.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:55 pm

LBTYA

Liberty Global announced plans to spin off 100% of Sunrise to its shareholders, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:54 pm

OPEN

Opendoor Technologies' stock price has decreased following the release of their Q4 earnings report.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:51 pm

TGTX

TG Therapeutics (NYSE:TGTX) has seen a decrease in short interest, now at 23.68% of its float, down 5.17% from the last report. With 29.12 million shares sold short, it would take about 7.19 days to cover all short positions. This change in short interest could indicate shifting market sentiment towards TGTX, potentially signaling a more bullish outlook among investors. TGTX's short interest is higher than its peer group average of 13.96%, suggesting it is more heavily shorted than similar companies.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 6:45 pm

CBRE

CBRE Group (NYSE:CBRE) has seen a decrease in short interest, with the short percent of float falling 5.02% since the last report, now at 2.08% of all shares available for trading. This decline in short interest could indicate a more bullish sentiment towards CBRE among traders. The company's short interest is also lower than its peer group average of 7.02%, suggesting a relatively positive outlook compared to its peers.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 6:45 pm